EpiCypher
EpiCypher is a Durham, NC-based epigenetics company and global leader in recombinant nucleosome manufacturing, founded in 2012 by leading chromatin biology researchers. The company develops CUTANA genomic mapping assays, designer nucleosomes, and epigenetics reagents and services used by academic and biopharma researchers to advance chromatin biology and drug development.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJun 2024
Jan 2021
Mar 2013
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Biotech venture firm and therapeutics accelerator that invests at seed stage and acts as a drug d...
